Francisco J Cueto
Overview
Explore the profile of Francisco J Cueto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
2365
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mata-Martinez P, Celada L, Cueto F, Saenz de Santa Maria G, Fernandez J, Terron-Arcos V, et al.
J Exp Clin Cancer Res
. 2025 Mar;
44(1):82.
PMID: 40038821
Background: Neuroendocrine neoplasms (NENs) comprise a group of rare tumors originating from neuroendocrine cells, which are present in both endocrine glands and scattered throughout the body. Due to their scarcity...
2.
Lozano-Rodriguez R, Avendano-Ortiz J, Montalban-Hernandez K, Ruiz-Rodriguez J, Ferrer R, Martin-Quiros A, et al.
EBioMedicine
. 2023 Oct;
97:104841.
PMID: 37890368
Background: Sepsis is associated with T-cell exhaustion, which significantly reduces patient outcomes. Therefore, targeting of immune checkpoints (ICs) is deemed necessary for effective sepsis management. Here, we evaluated the role...
3.
Rubio C, Avendano-Ortiz J, Ruiz-Palomares R, Karaivanova V, Alberquilla O, Sanchez-Dominguez R, et al.
Cancers (Basel)
. 2022 Jan;
14(2).
PMID: 35053451
Bladder cancer (BC) is the second most frequent cancer of the genitourinary system. The most successful therapy since the 1970s has consisted of intravesical instillations of (BCG) in which the...
4.
Brandi P, Conejero L, Cueto F, Martinez-Cano S, Dunphy G, Gomez M, et al.
Cell Rep
. 2022 Jan;
38(1):110184.
PMID: 34986349
MV130 is an inactivated polybacterial mucosal vaccine that confers protection to patients against recurrent respiratory infections, including those of viral etiology. However, its mechanism of action remains poorly understood. Here,...
5.
Hernandez-Garcia E, Cueto F, Cook E, Redondo-Urzainqui A, Charro-Zanca S, Robles-Vera I, et al.
Cell Mol Immunol
. 2022 Jan;
19(2):260-275.
PMID: 34983945
Conventional dendritic cells (cDCs) scan and integrate environmental cues in almost every tissue, including exogenous metabolic signals. While cDCs are critical in maintaining immune balance, their role in preserving energy...
6.
Cueto F, Del Fresno C, Brandi P, Combes A, Hernandez-Garcia E, Sanchez-Paulete A, et al.
J Immunother Cancer
. 2021 May;
9(5).
PMID: 33980589
Background: Conventional type 1 dendritic cells (cDC1s) are central to antitumor immunity and their presence in the tumor microenvironment associates with improved outcomes in patients with cancer. DNGR-1 (CLEC9A) is...
7.
Cueto F, Sancho D
Cancers (Basel)
. 2021 Apr;
13(7).
PMID: 33810248
Dendritic cells (DCs) prime anti-tumor T cell responses in tumor-draining lymph nodes and can restimulate T effector responses in the tumor site. Thus, in addition to unleashing T cell effector...
8.
Cueto F, Del Fresno C, Sancho D
Front Immunol
. 2020 Mar;
10:3146.
PMID: 32117205
DNGR-1 (encoded by ) is a C-type lectin receptor (CLR) with an expression profile that is mainly restricted to type 1 conventional dendritic cells (cDC1s) both in mice and humans....
9.
Del Fresno C, Cueto F, Sancho D
Curr Top Microbiol Immunol
. 2020 Jan;
429:117-145.
PMID: 31974758
After both sterile and infectious insults, damage is inflicted on tissues leading to accidental or programmed cell death. In addition, events of programmed cell death also take place under homeostatic...
10.
Del Fresno C, Cueto F, Sancho D
Front Immunol
. 2019 Sep;
10:2098.
PMID: 31555291
Myeloid C-type lectin receptors (CLRs) comprise a family of receptors expressed by immune myeloid cells that share homologous C-type lectin domains. The implication of these CLRs in the regulation of...